ACM
SRPT icon

Aquatic Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Aquatic Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51,728
Closed -$1.13M – 1706
2026
Q1 		$1.13M Sell
51,728
-194,607
-79% -$3.77M 0.03% 533
2025
Q4 		$5.3M Buy
246,335
+57,882
+31% +$1.22M 0.15% 171
2025
Q3 		$3.63M Sell
188,453
-27,364
-13% -$488K 0.07% 344
2025
Q2 		$3.69M Buy
215,817
+123,501
+134% +$5.27M 0.07% 311
2025
Q1 		$5.89M Buy
+92,316
New +$9.72M 0.15% 180
2024
Q2 		– Sell
-9,400
Closed -$1.22M – 1577
2024
Q1 		$1.22M Sell
9,400
-50,100
-84% -$6.14M 0.04% 348
2023
Q4 		$5.74M Buy
+59,500
New +$5.71M 0.15% 158
2023
Q3 		– Sell
-27,400
Closed -$3.14M – 1623
2023
Q2 		$3.14M Buy
27,400
+11,900
+77% +$1.53M 0.17% 139
2023
Q1 		$2.14M Buy
15,500
+12,600
+434% +$1.63M 0.13% 172
2022
Q4 		$375K Buy
+2,900
New +$336K 0.03% 572
2022
Q2 		– Sell
-200
Closed -$16K – 1555
2022
Q1 		$16K Buy
+200
New +$15.3K 0.02% 553

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Aquatic Capital Management's SRPT Position: Q2 2026 in Review

Aquatic Capital Management sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 51,728 shares — an estimated $1.13M sold.

Aquatic Capital Management first reported a position in SRPT in Q1 2022 and held it in 11 quarters. The position peaked at $5.89M in Q1 2025. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Aquatic Capital Management reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 51,728 Sarepta Therapeutics shares in Q2 2026, an estimated $1.13M.
  • Aquatic Capital Management first reported a position in Sarepta Therapeutics in Q1 2022 and held it in 11 quarters.
  • Aquatic Capital Management's Sarepta Therapeutics position peaked at $5.89M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.